benzoicacid,Novonorm,Prandin,RepaglinideProperties:
| RelatedCategories | AnalyticalStandards,Analytical/Chromatography,EPStandards,EPStandardsP-R,Pharmacopeia&MetrologicalInstitutesStandards |
Description:
Caution
PleasefindSDSprovidedbyEDQMhere.
.
Generaldescription
ThisproductisprovidedasdeliveredandspecifiedbytheissuingPharmacopoeia.Allinformationprovidedinsupportofthisproduct,includingSDSandanyproductinformationleafletshavebeendevelopedandissuedundertheAuthorityoftheIssuingPharmacopoeia.ForfurtherinformationandsupportpleasegotothewebsiteoftheissuingPharmacopoeia
.
OtherNotes
Salesrestrictionsmayapply.
Packaging
Unitquantity:6mg.Subjecttochange.TheproductisdeliveredassuppliedbytheissuingPharmacopoeia.Forthecurrentunitquantity,pleasevisittheEDQMreferencesubtancecatalogue
.
Biochem/physiolActions
Repaglinideisapotentshort-actinginsulinsecretagoguethatactsbyclosingATP-sensitivepotassium(KATP)channelsintheplasmamembraneofthepancreaticbetacell.Itrepresentsanewclassofinsulinsecretagogues,structurallyunrelatedtosulphonylureas,whichweredevelopedforthetreatmentoftype2diabetes.
Safety:
RIDADR
NONHforallmodesoftransport